We believe that the observed plateau in the response to vaccination in B16F10 tumor model is due to the limited tumor antigen variety (mutational burden) and exposure (low MHC expression) compared to the CT26 tumor model (25, 26, 37). Here, HLA-C is linked to neoplasm.